Live recombinant vaccines using genetically engineered vaccinia virus.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis* / Q000235:genetics; D000956:Antigens, Viral / Q000235:genetics* / Q000276:immunology; D004274:DNA, Recombinant; D005814:Genes, Viral; D005818:Genetic Engineering; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology; D007111:Immunity, Cellular; D007117:Immunization, Secondary; D011817:Rabbits; D012703:Serotyping; D013997:Time Factors; D014611:Vaccination; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology*; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D004274:DNA, Recombinant; D006514:Hepatitis B Surface Antigens; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C039447:glycoprotein D, Human herpesvirus 1